These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 26203970)

  • 1. Update on the treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
    Nobile-Orazio E; Gallia F
    Curr Opin Neurol; 2015 Oct; 28(5):480-5. PubMed ID: 26203970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: treatment update.
    Nobile-Orazio E; Gallia F; Tuccillo F; Terenghi F
    Curr Opin Neurol; 2010 Oct; 23(5):519-23. PubMed ID: 20689427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go.
    Nobile-Orazio E
    J Peripher Nerv Syst; 2014 Mar; 19(1):2-13. PubMed ID: 24612201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
    Dalakas MC
    J Peripher Nerv Syst; 2012 May; 17 Suppl 2():34-9. PubMed ID: 22548621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigations and treatment of chronic inflammatory demyelinating polyradiculoneuropathy and other inflammatory demyelinating polyneuropathies.
    Tracy JA; Dyck PJ
    Curr Opin Neurol; 2010 Jun; 23(3):242-8. PubMed ID: 20389243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood acute and chronic immune-mediated polyradiculoneuropathies.
    Rabie M; Nevo Y
    Eur J Paediatr Neurol; 2009 May; 13(3):209-18. PubMed ID: 18585069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel immunotherapeutic strategies in chronic inflammatory demyelinating polyneuropathy.
    Mathis S; Vallat JM; Magy L
    Immunotherapy; 2016 Feb; 8(2):165-78. PubMed ID: 26809024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current treatments of chronic immune-mediated demyelinating polyneuropathies.
    Brannagan TH
    Muscle Nerve; 2009 May; 39(5):563-78. PubMed ID: 19301378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Cocito D; Paolasso I; Antonini G; Benedetti L; Briani C; Comi C; Fazio R; Jann S; Matà S; Mazzeo A; Sabatelli M; Nobile-Orazio E;
    Eur J Neurol; 2010 Feb; 17(2):289-94. PubMed ID: 19863650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy of CIDP and related immune-mediated neuropathies.
    Koski CL
    Neurology; 2002 Dec; 59(12 Suppl 6):S22-7. PubMed ID: 12499467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: the ICE trial.
    Hughes RA
    Expert Rev Neurother; 2009 Jun; 9(6):789-95. PubMed ID: 19496683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic inflammatory demyelinating polyradiculoneuropathy.
    Van den Bergh PY; Rajabally YA
    Presse Med; 2013 Jun; 42(6 Pt 2):e203-15. PubMed ID: 23623582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Office immunotherapy in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy.
    Dyck PJ; Taylor BV; Davies JL; Mauermann ML; Litchy WJ; Klein CJ; Dyck PJ
    Muscle Nerve; 2015 Oct; 52(4):488-97. PubMed ID: 25976871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases.
    Larue S; Bombelli F; Viala K; Neil J; Maisonobe T; Bouche P; Musset L; Fournier E; Léger JM
    Eur J Neurol; 2011 Jun; 18(6):899-905. PubMed ID: 21199182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum IgG levels as biomarkers for optimizing IVIg therapy in CIDP.
    van Doorn PA; Kuitwaard K; Jacobs BC
    J Peripher Nerv Syst; 2011 Jun; 16 Suppl 1():38-40. PubMed ID: 21696496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the use of biological agents for chronic inflammatory demyelinating polyradiculoneuropathy.
    Stübgen JP
    J Neurol Sci; 2013 Mar; 326(1-2):1-9. PubMed ID: 23337197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic reviews of treatment for chronic inflammatory demyelinating neuropathy.
    Hughes RA
    Rev Neurol (Paris); 2002 Dec; 158(12 Pt 2):S32-6. PubMed ID: 12690659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic inflammatory demyelinating polyradiculoneuropathy: update on clinical features, phenotypes and treatment options.
    Eftimov F; van Schaik I
    Curr Opin Neurol; 2013 Oct; 26(5):496-502. PubMed ID: 23852276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroids for chronic inflammatory demyelinating polyradiculoneuropathy: evidence base and clinical practice.
    Press R; Hiew FL; Rajabally YA
    Acta Neurol Scand; 2016 Apr; 133(4):228-38. PubMed ID: 26437234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting response to treatment in chronic inflammatory demyelinating polyradiculoneuropathy.
    Chan YC; Allen DC; Fialho D; Mills KR; Hughes RA
    J Neurol Neurosurg Psychiatry; 2006 Jan; 77(1):114-6. PubMed ID: 16361609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.